Related Experiment Video

Updated: Oct 13, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.5K

Acute-on-chronic liver failure in children

Ali Islek1, Gokhan Tumgor2

  • 1Department of Pediatric Gastroenterology, Cukurova University School of Medicine, Adana 01330, Turkey.

World Journal of Hepatology
|November 17, 2021
PubMed

Insights

Acute-on-chronic liver failure (ACLF) lacks a universal pediatric definition. Early recognition of pediatric ACLF is crucial for timely intervention and improved outcomes, as it indicates a poor prognosis.

Area of Science:

  • Pediatric Hepatology
  • Critical Care Medicine

Background:

  • Acute-on-chronic liver failure (ACLF) is a severe clinical syndrome characterized by acute liver decompensation in patients with underlying chronic liver disease.
  • Pediatric ACLF presents unique challenges due to differences in acute events and chronic liver diseases compared to adults.
  • Geographical variations exist in the prevalence of underlying liver diseases and precipitating factors for ACLF in children.

Purpose of the Study:

  • To highlight the current lack of a universal definition for pediatric acute-on-chronic liver failure (ACLF).
  • To emphasize the distinct characteristics of ACLF in children compared to adults.
  • To underscore the importance of early recognition and management of pediatric ACLF.

Main Methods:

  • Review of existing literature on acute-on-chronic liver failure (ACLF) definitions and pediatric cases.
  • Comparison of etiological factors and clinical presentations of ACLF in pediatric and adult populations.
  • Evaluation of current prognostic scoring systems and their applicability to pediatric ACLF.

Main Results:

  • There is no universally accepted definition for pediatric acute-on-chronic liver failure (ACLF).
  • Common causes in children include autoimmune hepatitis and Wilson's disease flares, differing from adult populations.
  • Modified adult scoring systems (APASL ACLF, CLIF-SOFA) can be tentatively used for prognosis in children.

Conclusions:

  • Early identification of pediatric ACLF is critical to prevent extrahepatic organ failure.
  • Liver transplantation remains the primary definitive treatment for pediatric ACLF.
  • Development of specific, validated prognostic scoring systems for pediatric ACLF is urgently needed.

Keywords:
ClinicsHistopathologyLiver failurePrevalencePrognosisScoring systemsTreatment

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

173
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.7K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
21
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
21
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
31
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
134
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21